Imagen Technologies

224 W 35th St #500, New York, NY 10001, United States  All United States companies → — Founded 2015
Imaging AI Specialist
Cardiology Emergency Medicine Internal Medicine Orthopedics
Cardiology AI Clinical Decision Support & Reference Oncology AI Radiology & Imaging AI
Series C — Over $200 million
Claim this company

Products

Imagen OsteoDetect
Imagen Technologies
Clinical Decision Support & Reference
Imagen OsteoDetect is an FDA-cleared AI-driven software that assists clinicians in detecting distal radius fractures on adult wrist X-rays, enhancing diagnostic accuracy and speed.
Aorta-CAD
Imagen Technologies
Cardiology AI
Aorta-CAD by Imagen Technologies is an FDA-cleared, cloud-based AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, integrating seamlessly into existing workflows.
Contact for pricing
OsteoDetect
Imagen Technologies
Radiology & Imaging AI
OsteoDetect is the first ever FDA-cleared software device for Radiological Computer Aided Diagnosis/Detection (CAD). It uses AI to help detect and localize distal radius fractures – the most commonly misdiagnosed musculoskeletal injury.
Contact vendor for pricing

See all 6 products →

About Imagen Technologies

Imagen Technologies is a healthcare AI company dedicated to transforming diagnostic imaging through an end-to-end, AI-enabled platform. Their solutions are designed to enhance diagnostic accuracy, reduce costs, and expand access to high-quality medical image interpretation. The company’s FDA-cleared AI algorithms are integrated into clinical workflows, assisting board-certified, sub-specialized clinicians in real-time interpretation of studies and highlighting critical findings for faster and more precise diagnoses.

Imagen Technologies provides comprehensive services including in-clinic imaging equipment, AI-enabled interpretations, and advanced imaging analytics. Their technology supports various modalities such as X-ray, mammography, and fundoscopy, with specific FDA-cleared software like OsteoDetect for distal radius fractures. The company’s mission is rooted in preventing diagnostic errors, leveraging a vertically integrated approach that combines in-house AI development with clinical service operations to ensure real-world safety and efficacy.

Focus Areas

medical image analysis artificial intelligence AI-enabled diagnostic imaging solutions Diagnostics as a Service (DaaS) primary care radiology clinical decision support fracture detection distal radius fractures musculoskeletal imaging aortic atherosclerosis aortic ectasia lung pathologies pulmonary fibrosis COPD mammography fundoscopy X-ray remote cardiac monitoring

Business Intelligence

Key InvestorsSummit Partners, NFX, Downing Ventures, Cambridge Innovation Capital, GV, Casdin Capital, Threshold Ventures, Zach Weinberg, Allen & Company, DFJ
AcquisitionsNone
TechnologyAI-enabled diagnostic imaging platform, Diagnostics as a Service (DaaS) platform, cloud-based, software-only medical device, deep learning, AI-enabled software integrated into PACS environment, cloud infrastructure, vertically integrated AI company, machine learning
FDA Clearances5 cleared products (estimated)

What Physicians Need to Know

AI-Enabled Diagnostic Imaging
Imagen Technologies specializes in medical image analysis using FDA-cleared deep-learning-based Computer Assisted Detection (CADe) software across various modalities. Their solutions include FractureDetect and OsteoDetect for musculoskeletal imaging and fracture detection (including distal radius fractures), Aorta-CAD for detecting findings suggestive of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, Chest-CAD for general chest X-ray abnormalities, and Lung-CAD for identifying interstitial thickening and lung hyperinflation, suggestive of pulmonary fibrosis and COPD.
Diagnostics as a Service (DaaS)
They offer a comprehensive DaaS platform that integrates imaging equipment, technical staff, board-certified radiologists, and proprietary FDA-cleared AI devices directly into practices. This end-to-end solution aims to improve patient experience, empower primary care physicians with earlier diagnoses, and enhance care quality.
Primary Care Integration
A core focus is on enabling primary care physicians (PCPs) to offer a broader range of diagnostic services, such as X-ray, mammography, and fundoscopy, directly within their practices. This approach improves access, speeds up results, and reduces the need for external referrals.
Key Differentiators
Imagen stands out with multiple FDA-cleared AI algorithms, a vertically integrated model controlling the entire image acquisition and interpretation process, and AI models trained on vast, diverse datasets of tens of millions of medical images. They emphasize rigorous evaluation, peer-reviewed research, and a commitment to patient safety and outcomes.
Technology Stack
Their core technology revolves around advanced machine learning and deep learning algorithms for medical image analysis. Their solutions are cloud-based, and they utilize technologies like Python, JavaScript, Flask, React, and PostgreSQL for their software development.
Specific Imaging Modalities & Conditions
Imagen's expertise covers X-ray, mammography, fundoscopy, and remote cardiac monitoring. Their AI assists in detecting fractures across the musculoskeletal system, identifying signs of aortic atherosclerosis and ectasia, and highlighting lung pathologies like interstitial thickening and lung hyperinflation.
Physician Tip

For physicians, Imagen Technologies offers significantly improved diagnostic accuracy and reduced misinterpretation rates through their FDA-cleared AI-enabled software, acting as a concurrent reading aid. This leads to earlier disease detection and better patient outcomes. The DaaS platform and primary care integration allow for faster, in-office diagnostics, reducing patient wait times and unnecessary referrals, while also streamlining workflows and potentially reducing physician burnout by handling higher caseloads with AI assistance and comprehensive operational support. Radiologists benefit from flexible remote work options and a physician-led culture that values autonomy and innovation.

Imagen's DaaS platform and AI software are designed for seamless integration into existing X-ray reading workflows and Picture Archiving and Communication System (PACS) viewers, eliminating the need for new PACS technology or costly retraining. They emphasize working with existing tech stacks and integrating with industry-leading software to enhance efficiency and accessibility.

Products by Imagen Technologies

6 products in the directory

Imagen OsteoDetect
Imagen Technologies
Clinical Decision Support & Reference
Imagen OsteoDetect is an FDA-cleared AI-driven software that assists clinicians in detecting distal radius fractures on adult wrist X-rays, enhancing diagnostic accuracy and speed.
Aorta-CAD
Imagen Technologies
Cardiology AI
Aorta-CAD by Imagen Technologies is an FDA-cleared, cloud-based AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, integrating seamlessly into existing workflows.
Contact for pricing
OsteoDetect
Imagen Technologies
Radiology & Imaging AI
OsteoDetect is the first ever FDA-cleared software device for Radiological Computer Aided Diagnosis/Detection (CAD). It uses AI to help detect and localize distal radius fractures – the most commonly misdiagnosed musculoskeletal injury.
Contact vendor for pricing
FractureDetect (FX)
Imagen Technologies
Radiology & Imaging AI
FractureDetect (FX) by Imagen Technologies is an FDA-cleared AI-powered computer-assisted detection and diagnosis (CAD) software device designed to assist clinicians in detecting hard-to-spot fractures on musculoskeletal radiographs in adults, thereby improving diagnostic accuracy and reducing missed fractures.
Contact for pricing
Chest-CAD
Imagen Technologies
Clinical Decision Support & Reference
Chest-CAD by Imagen Technologies is an FDA-cleared AI software that detects, categorizes, and localizes suspicious regions on adult chest X-rays, shown to reduce diagnostic errors by 40%.
Contact for pricing
Lung-CAD
Imagen Technologies
Oncology AI
Imagen Technologies provides FDA-cleared, AI-enabled diagnostic imaging software, including Lung-CAD, to enhance diagnostic quality, efficiency, and patient care in radiology and primary care settings.
Contact for pricing

What the Web Says

Imagen Technologies receives mixed reviews, with some praising its innovative AI technology for medical diagnostics and positive workplace culture, while others express concerns about product stability, customer support, and internal management. The company's mission and potential are often highlighted, but execution and employee experience can vary.

Overall: Mixed

Strengths

  • Innovative AI technology for medical diagnostics (e.g., bone fracture detection)
  • Strong company mission and vision to improve healthcare
  • Positive feedback on workplace culture and supportive colleagues (Glassdoor)
  • Potential to significantly impact patient care and efficiency
  • Good benefits package for employees (Glassdoor)
  • Opportunities for professional growth and learning

Limitations

  • Product stability and bug issues reported by some users (G2, healthcare IT forums)
  • Customer support responsiveness and effectiveness can be inconsistent
  • Concerns about internal management and leadership decisions (Glassdoor)
  • High workload and potential for burnout in some roles
  • Integration challenges with existing healthcare IT systems
  • Compensation not always competitive with larger tech companies (Glassdoor)

Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT News/Review Sites, Reddit

Last updated: 2026-07-18

Videos

News, demos, and interviews about Imagen Technologies.

Loading videos...

Videos load interactively. If none appear, search YouTube for Imagen Technologies →

View all on YouTube

Press & Coverage

Nature
Deep learning improves physician accuracy in the comprehensive detection of abnormalities on chest X-rays
A study published in Nature in October 2024 found that Imagen's AI software significantly improved the accuracy and speed of physicians, especially non-radiologists, in interpreting chest X-rays, making them as accurate as radiologists.
2024-10
Vertex AI Search
Imagen Technologies, Inc. Funding and Investor Information
Imagen Technologies raised a $32 million Series C funding round on December 7, 2024, led by Summit Partners, to accelerate product development, expand go-to-market strategies, and enter new markets.
2024-12
Imagen Newsroom
Imagen Achieves HITRUST Risk-based, 2-year Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
Imagen Technologies announced on August 29, 2023, that it achieved HITRUST Risk-based, 2-year Certification, validating its commitment to robust cybersecurity and compliance with regulations for protecting sensitive data.
2023-08
PR Newswire
Imagen Technologies Announces FDA Clearance of Aorta-CAD
On December 5, 2022, Imagen Technologies announced FDA 510(k) clearance for Aorta-CAD, an AI-powered device designed to assist physicians in detecting findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia.
2022-12
Clinical Orthopaedics and Related Research
Deep-learning assistance closes the accuracy gap in fracture detection across clinician types
A study published on September 7, 2022, demonstrated that Imagen's FDA-cleared AI software, FractureDetect, improved the accuracy of clinicians, including those with limited training, in diagnosing fractures on musculoskeletal radiographs.
2022-09
Respiratory Medicine Case Reports
Reevaluation of missed lung cancer with artificial intelligence
A case study published on March 28, 2022, highlighted how Imagen's FDA-cleared AI software, Chest-CAD, identified a previously missed suspicious region on a chest X-ray, demonstrating its potential to detect life-threatening findings.
2022-03
accessdata.fda.gov
Imagen Technologies, Inc. 510(k) Premarket Notification for Chest-CAD
On July 20, 2021, the FDA reviewed Imagen Technologies' 510(k) premarket notification for Chest-CAD, a computer-assisted detection (CADe) software device intended to assist physicians in identifying suspicious regions of interest in adult chest X-rays.
2021-07
Built In
Imagen Technologies Company Growth, Stability & Outlook 2026
As of April 2026, Imagen Technologies is described as operating across many U.S. states with a growing clinic footprint and patient coverage, indicating broadening geographic and delivery reach, and has achieved multiple FDA clearances for its radiology AI tools.
2026-04

Frequently Asked Questions

Imagen Technologies offers several FDA-cleared AI software solutions, including OsteoDetect for detecting distal radius fractures on X-rays, FractureDetect for general fracture detection, and Chest-CAD for identifying suspicious regions on chest X-rays, which can aid in detecting lung pathologies. Additionally, Aorta-CAD assists physicians in detecting findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia.
Imagen's DaaS platform provides an end-to-end solution that enables primary care physicians and radiologists to offer in-office imaging, including X-ray, mammography, and fundoscopy, with minimal upfront investment. This model includes equipment, IT integration, staffing, and AI-enabled interpretations by board-certified specialists, enhancing diagnostic accuracy and providing clinical decision support at the point of care.
Imagen Technologies' AI software, such as OsteoDetect and Aorta-CAD, are FDA-cleared, with OsteoDetect being the first FDA-cleared CADe/x software for radiology. The company emphasizes rigorous evaluation through large-scale clinical trials and holds HITRUST Risk-based Certification for robust cybersecurity and data protection.
Imagen Technologies provides comprehensive, end-to-end support for its DaaS platform, including installation management, EMR integration, staffing of technologists, accreditation assistance, and ongoing administrative support like patient outreach and revenue cycle management. They offer 24/7 emergency support via a direct contact for timely assistance. While they emphasize an integrated partnership model with physicians, specific external technology partnerships beyond this are not prominently detailed in the provided information for their medical imaging division.
The pricing structure for Imagen Technologies' medical DaaS platform and AI solutions is not publicly detailed in a per-image or subscription model like some other Imagen entities. Given the comprehensive nature of their DaaS offering, which includes equipment, software, and operational support, pricing is likely customized based on the specific needs and scale of each healthcare provider or system. Interested parties would need to contact Imagen Technologies directly for a tailored quote.
Founded in 2015, Imagen Technologies has demonstrated strong company stability, having raised significant capital, including $135 million from investors like Google Ventures and Casdin Capital. With over 100 personnel and a vertically integrated approach to AI-enabled diagnostics, they are positioned for continued growth by improving diagnostic accuracy, accessibility, and efficiency in healthcare.
Based on the available information, Imagen Technologies primarily focuses on AI-enabled diagnostic imaging solutions for in-clinic use, such as X-ray, mammography, fundoscopy, and echocardiography, rather than remote cardiac monitoring. While they aim to bring imaging into practices, specific products or services for remote cardiac monitoring are not a highlighted offering.

Comparisons

DeepXray vs Chest-CAD
BriefCase vs Chest-CAD
Aorta-CAD vs EchoNext
Aorta-CAD vs PMcardio

Related Companies

QuickIntell
Chicago, IL, USA

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief
Kulpsville, PA

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed (Niedersächsisches Zentrum für KI und Kausale Methoden in der Medizin)
Hannover, Germany (Lower Saxony region)

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm
Berkeley, United States and London, United Kingdom. European office in Barcelona, Spain and Gothenburg, Sweden.

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA
London, UK

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics
London, United Kingdom

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
Suggest an Edit →
AI Tool Finder
AI-powered search. Results may not be comprehensive.